Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6207802

Title:Stem cell factor and compositions
Inventors:Zsebo, Krisztina M.; Thousand Oaks, CA, USA
Bosselman, Robert A.; Thousand Oaks, CA, USA
Suggs, Sidney V.; Newbury Park, CA, USA
Martin, Francis H.; Thousand Oaks, CA, USA
Summary:Described herein is a novel isolated and purified non-human mammalian stem cell factor polypeptide which stimulates the growth of early hematopoietic progenitor cells. The invention relates to novel stem cell factors, the oligonucleotides encoding such factors, and methods of their production. Therapeutic applications are included, such as in the treatment of aplastic anemia, lymphoma, Letterer-Siwe disease, Kala azar, and sarcoidosis. This invention represents a continuation of other applications filed by the same assignee and inventors.
Abstract:Novel stem cell factors, oligonucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders involving blood cells are also disclosed.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6207802
Application Number:US1994000336728
Date Filed:09/11/1994
Date Published:27/03/2001
Assignee:Amgen Inc., Thousand Oaks, CA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/22/2021